Stockholders' Equity - Additional Information (Details) - USD ($)										1 Months Ended					12 Months Ended
		Aug. 16, 2019	Jul. 15, 2019	May 14, 2019	Feb. 06, 2019	Feb. 06, 2019	Jan. 14, 2019	Jan. 02, 2019	Jan. 08, 2018	Feb. 13, 2019	Dec. 21, 2018	Jul. 24, 2018	Apr. 16, 2018	Jan. 29, 2018	Dec. 31, 2019	Dec. 31, 2018		Mar. 06, 2018	Jan. 05, 2018
Stock Issued During Period, Shares, New Issues			5,046,763		236,466									2,730,000
Shares Issued, Price Per Share														$ 10.00
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options															$ 3,249,222
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition															1 year 10 months 24 days
Net Proceeds From Issuance Of Common Stock			$ 13,000,000											$ 24,500,000
Payment of Financing and Stock Issuance Costs														$ 2,800,000
Convertible Preferred Stock, Shares Issued upon Conversion														4,702,116
Share-based Compensation Arrangement by Share-based Payment Award, Description																vest over three years from the date of grant with one-third vesting on the one-year anniversary of the date of grant and the balance vesting monthly over the remaining 24 months
Gross Proceeds Of Stock Value Issued During Period			$ 14,000,000											$ 27,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value													$ 1,412,700
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							3 years						36 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross													175,668
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price							$ 2.74						$ 8.72		$ 3.10	$ 6.39
Share-based Compensation															$ 2,511,944	$ 1,615,470
Sharebased Compensation Arrangement by Sharebased Payment Award Options Grants in Period Grant Date Fair Value							$ 27,500									2,237,800
Proceeds from Issuance of Common Stock	[1]														13,214,949	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross													175,668
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost															609,322
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				34,815	320,001
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price				$ 1.95		$ 1.24
Stockholders' Equity, Reverse Stock Split									1-for-3.75
Remittance of employee's Payroll Taxes								$ 62,193
Proceeds from Stock Options Exercised				$ 67,889				$ 483,888							551,777	56,482
Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number										124,210
Research and Development Expense [Member]
Share-based Compensation															1,459,055	818,239
General and Administrative Expense [Member]
Share-based Compensation															$ 1,052,889	$ 797,231
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 125,000										$ 125,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		40,190										20,165
Common Stock [Member]
Shares Issued, Price Per Share											$ 2.45
Payment of Financing and Stock Issuance Costs											$ 600,000
Proceeds Of Stock Issued During Period Gross											2,800,000
Proceeds from Issuance of Common Stock											$ 3,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period								133,686							34	28,965
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price								$ 1.95
Stock Issued During Period Shares New Issues Two											1,380,000					1,380,000	[2]
IPO [Member]
Stock Issued During Period, Shares, New Issues			4,388,490
Shares Issued, Price Per Share			$ 2.78
Over-Allotment Option [Member]
Stock Issued During Period, Shares, New Issues			658,273
Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		636,287					11,000									313,674
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		636,287					11,000									313,674
Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		24 months					24 months									36 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		45,285														60,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		45,285														60,000
Share-based Compensation Award, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																22,325
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																22,325
Maximum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																$ 6.30
Minimum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																$ 5.10
Employees Consultants and Directors Under the 2018 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		681,572					11,000									395,999
Sharebased Compensation Arrangement by Sharebased Payment Award Options Grants in Period Grant Date Fair Value		$ 1,909,700
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		681,572					11,000									395,999
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price		$ 3.11
Omnibus Stock Incentive Plan 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																		1,250,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant															106,074
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant															15,333
Equity Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																			1,866,667
Equity Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																			1,733,333
Series A Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period																0
Stock Issued During Period Shares New Issues Two	[2]															0
Series B Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period																0
Convertible Preferred Stock, Terms of Conversion															The Series B Convertible Preferred did not contain a redemption provision and an overall analysis of its features performed by the Company determined that it was more akin to equity and therefore, has been classified within stockholders' equity on the balance sheet. While the embedded conversion option ("ECO") was subject to an anti-dilution price adjustment, since the ECO was clearly and closely related to the equity host, it was not required to be bifurcated and accounted for as a derivative liability under ASC 815. The Company determined that the Series B Convertible Preferred did not contain a beneficial conversion feature, since the conversion price exceeded the estimated fair value of the Company's common stock as of the commitment date.The Series B Convertible Preferred Stock was convertible, at the option of the holder, at any time into shares of common stock on a one-for-one basis, subject to certain adjustments. In the event of any issuances by the Company for less than the in-force conversion price, the Series B Convertible Preferred Stock conversion price would be reduced on a weighted average basis. Each share of Series B Convertible Preferred Stock was automatically convertible into shares of common stock at the then effective conversion price: (i) immediately prior to the closing of a firm commitment underwritten initial public offering provided that (A) the aggregate offering price, net of underwriters' discounts and expenses, is at least $2.00 per share of common stock and (B) the aggregate proceeds of such offering are not less than $20,000,000; or (ii) the date specified by written consent or agreement of the holders of at least 75% of the then outstanding shares of preferred stock.
Stock Issued During Period Shares New Issues Two	[2]															0
Series And Series A2 Convertible Preferred Stock [Member]
Convertible Preferred Stock, Terms of Conversion															The Series A and Series A-2 Convertible Preferred Stock was convertible, at the option of the holder, at any time into shares of common stock on a one-for-one basis. In the event of any issuances by the Company for less than the in-force conversion price, the preferred stock conversion price would be reduced on a weighted average basis. Each share of preferred stock was automatically convertible into shares of common stock at the then effective conversion price: (i) immediately prior to the closing of a firm commitment underwritten initial public offering provided that (A) the aggregate offering price, net of underwriters' discounts and expenses, was at least $2.00 per share of common stock and (B) the aggregate proceeds of such offering were not less than $20,000,000; or (ii) the date specified by written consent or agreement of the holders of at least 75% of the then outstanding shares of preferred stock.

[1] [3] Includes gross proceeds of $14,030,001, less total issuance costs of $815,052 deducted directly from the offering proceeds.

[2] [2] Includes gross proceeds of $3,381,000, less total issuance costs of $563,251.